As the Vice President of Product Development at Ablative Solutions, Jason Fortier plays a pivotal role in advancing innovative solutions for hypertension treatment through a unique combination device that integrates chemical renal denervation technology. With extensive experience in product development and management across the chemistry,...
As the Vice President of Product Development at Ablative Solutions, Jason Fortier plays a pivotal role in advancing innovative solutions for hypertension treatment through a unique combination device that integrates chemical renal denervation technology. With extensive experience in product development and management across the chemistry, medical device, and pharmaceutical sectors, Jason has successfully transformed clinical concepts into commercially viable products. His leadership in proprietary catheter development and comprehensive oversight of drug development and CMC (Chemistry, Manufacturing, and Controls) activities underscores his expertise in navigating complex regulatory landscapes, particularly with the U.S. Food and Drug Administration (FDA).
Jason’s strategic vision is complemented by his proven track record in building high-performing teams and fostering cross-functional collaboration. His adeptness in program management and budgeting ensures that projects are delivered on time and within scope, while his deep understanding of quality systems and ISO 14971 compliance guarantees that all products meet stringent safety and efficacy standards. He is also skilled in the design of experiments, which enhances the product development process by enabling data-driven decision-making.
Key projects under Jason’s leadership include the development of innovative renal denervation devices that leverage cutting-edge technology to improve patient outcomes. By cultivating relationships with key opinion leaders (KOLs) and stakeholders, Jason not only drives product pipeline management but also ensures that Ablative Solutions remains at the forefront of medical advancements. His commitment to commercialization and team building positions him as a vital asset in the pursuit of transformative healthcare solutions.
